View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: Nagarro SE: Die Hauptversammlung von Nagarro am 27. Juni 202...

EQS-News: Nagarro SE / Schlagwort(e): Hauptversammlung Nagarro SE: Die Hauptversammlung von Nagarro am 27. Juni 2024 verabschiedet alle Beschlüsse und bestellt KPMG zum Abschlussprüfer 28.06.2024 / 13:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 28. Juni 2024 - Nagarro, ein weltweit führendes Unternehmen für Digital Engineering, hat am 27. Juni 2024 seine ordentliche Hauptversammlung in München abgehalten. Die Aktionärinnen und Aktionäre haben am gestrigen Tag mit großer Mehrheit alle Beschlussvorschläge des Aufsichtsrats und d...

 PRESS RELEASE

EQS-News: Nagarro SE: Nagarro’s Annual General Meeting of June 27, 202...

EQS-News: Nagarro SE / Key word(s): AGM/EGM Nagarro SE: Nagarro’s Annual General Meeting of June 27, 2024, passes all resolutions and appoints KPMG as auditor 28.06.2024 / 13:29 CET/CEST The issuer is solely responsible for the content of this announcement. June 28, 2024 - Nagarro, a global leader in digital engineering, held its Annual General Meeting in Munich on June 27, 2024. The shareholders approved all resolutions proposed by the Supervisory Board and the Management Board at yesterday’s Annual General Meeting by a vast majority, including the appointment of KPMG A...

Thomas J. Schiessle
  • Thomas J. Schiessle

Q2/24 erfreulich – Lagerabbau bei Standart-Vails abgeschlossen- CFO: Q...

FY 24 ist auf Kurs; der Markt intakt, aber das Kundenverhalten eher zurückhaltend. Im H1/24 stieg der Konzernumsatz (in CC) mit 9,0 % YoY auf € 489 Mio. jüngst schneller. Das adj. EBITDA stieg auf € 134 Mio. (in CC.: +2 %; Marge 27,4 %; Vj: 29,4 %), sank (wg. Unterauslastung) im QoQ aber. Die Nachfrage nach Primärverpackungen für Flüssig-Medikamente ist anhaltend hoch, was u.E. ab H2/23-24 deutlich und margenrelevant (vor ramp-up-Kosten (FY 23-24: € 10-15 Mio.)) werden wird, denn der Corona-bedi...

Thomas J. Schiessle
  • Thomas J. Schiessle

Q2/24 pleasing - destocking of standard vails completed - CFO: Q3/24 i...

FY 24 is on track; market intact, but customer behavior rather cautious. In H1/24, Group sales (in CC) recently grew faster at 9.0% YoY to € 489m. Adj. EBITDA rose to € 134m (in CC.: +2%; margin 27.4%; PY: 29.4%), but fell (due to underutilization) in QoQ. Demand for primary packaging for liquid medicines remains high, which we believe will become significant and margin-relevant (before ramp-up costs (FY 23-24: € 10-15m)) from H2/23-24, as the corona-related customer destocking (especially vials...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf

SCHOTT Pharma AG & Co. KGaA : Positive newsflow on FY 24 guidance duri...

>FY 24 sales guidance is not limited to the lower end of the range any more - The most important topic of the H1 conference call was that the CFO, Dr Almuth Steinkühler, changed the tone on the 2024 sales guidance. Previously the company limited the guidance to the low end of its 9-11% sales growth target for FY 24 as FY 23 came in stronger than anticipated and therefore comps were challenging. At the conference call, the CFO explicitly emphasised that the full range ...

 PRESS RELEASE

H.C. Wainwright & Co. initie la couverture de Medincell avec une recom...

MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News: Medincell (Paris:MEDCL): Christophe Douat, président du directoire de Medincell, déclare : « L’initiation de couverture réalisée par l’équipe d’analystes de H.C. Wainwright& Co. et leur recommandation à l’achat témoignent du potentiel de Medincell. Cette initiation souligne l’intérêt croissant pour Medincell de la part du secteur biopharmaceutique aux Etats-Unis et participe à notre stratégie de renforcement notre visibilité auprès des investisseurs américains. » L’initiation de couverture de H.C. Wainwright & Co. intervient alors q...

 PRESS RELEASE

Viridien: Launch of Viridien reverse share split

Viridien: Launch of Viridien reverse share split Launch of Viridien (ex-CGG) reverse share split Paris, France – June 27, 2024 Viridien (the “Company”) announces the implementation of the reverse share split on the basis of 1 new share of €1.00 nominal value for 100 old shares of €0.01 nominal value (the “Reverse Share Split”). Pursuant to a delegation from the Combined General Meeting of shareholders of May 15, 2024, and a sub-delegation from the Board of Directors held on the same day, the Company's Chief Executive Officer has decided to implement this Reverse Share Split under the fol...

 PRESS RELEASE

Viridien : Lancement du regroupement des actions Viridien

Viridien : Lancement du regroupement des actions Viridien Lancement du regroupement des actions Viridien (ex-CGG) Paris, France – 27 juin 2024 Viridien (la « Société ») annonce la mise en œuvre des opérations de regroupement d’actions composant son capital social, à raison de 1 action nouvelle de 1,00 € de valeur nominale contre 100 actions anciennes de 0,01 € de valeur nominale (le « Regroupement »). Suivant délégation de pouvoirs de l’Assemblée Générale mixte des actionnaires du 15 mai 2024, et subdélégation du Conseil d’administration tenu le même jour, le Directeur Général de la Soc...

Stephane Beyazian
  • Stephane Beyazian

ODDO BHF Small & MIDCAP MORNING NEWS - 06/27/2024

As momentum has become less adverse than over the past five years, interest rates have started to fall and valuations have (historically low), this should have prodded small and mid cap companies back to their old outperformance. The European elections in France and the ensuing decision to dissolve the French National Assembly have changed risk perceptions and erased YTD gains. In our new ODDO BHF European mid cap list for H2 2024, France is underweighted with a mix of defensive and s...

Stephane Beyazian
  • Stephane Beyazian

ODDO BHF Small & MIDCAP MORNING NEWS - 27/06/2024

Le momentum devenu moins défavorable qu’au cours des 5 derniers exercices, l’amorce de baisse des taux, et les valorisations (historiquement basses) auraient dû aider les small&Midcaps à retrouver leur surperformance. Les Elections européennes suivies de la dissolution de l’Assemblée nationale en France ont changé la perception du risque et gommé les gains YTD. Notre nouvelle liste ODDO BHF European Midcaps pour le S2 2024 se trouve sous-pondérée sur la France et propose un mix entre ...

Konrad Zomer ... (+2)
  • Konrad Zomer
  • Stephane Beyazian

ODDO : Ericsson downgrades its global traffic outlook

>Unprecedented revision of 25% - Ericsson yesterday published its annual Ericsson Mobility report, an industry benchmark for mobile network traffic forecasts. Traffic forecasts are crucial in terms of the investment outlook for the telecoms sector.What is surprising is that Ericsson cut its global mobile traffic forecast by close to 25% for 2029 (from 403 EB/m to 313 EB/m, or from 56 to 42 GB/m per smartphone user). Ericsson does not communicate much on this revi...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf

SCHOTT Pharma AG & Co. KGaA : H1 results in line with preliminary figu...

>H1 was strongly impacted by FX headwinds - SCHOTT Pharma’s final H1 figures were in line with prel. results, which were published on 14 May 2024. In H1 2024, the company’s revenues grew by 9% to € 466m at constant currencies (H1 2023: € 449m). The company’s EBITDA increased slightly (+2% at cc / -11% reported) compared to the prior year despite ramp-up cost from the continued investments in capacity expansion. Revenues and EBITDA on a reported basis were impacted by ...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

Figeac Aero : Adjusted FCF 12.6% above our forecasts – Guidance for FY...

>A solid 2023-24 marked by an acceleration in FCF generation - Figeac has published solid 2023-24 results with adjusted EBITDA of € 52.2m (+29.6%) - broadly in line with our forecast for € 52.1m - for sales of € 397.2m, i.e. a margin of 13.2% (+140bp). Note that these figures include two unfavourable effects: i/ a loss of € 7.4m on operations in Mexico (the cost of which should fall to -€1m/-€ 1.5m in FY 2024-25) and ii/ a net impact of inflation of -€ 3.8m, with the ...

Olfa Taamallah ... (+2)
  • Olfa Taamallah
  • Yan Derocles

Figeac Aero : FCF ajusté 12.6% au-delà de nos attentes – Guidances FY ...

>Solide exercice 2023-24 marqué par une accélération de la génération de FCF - Figeac a publié de solides résultats 2023-24 avec un EBITDA Ajusté de 52.2 M€ (+29.6%) -globalement en ligne avec notre attente de 52.1 M€- pour un CA de 397.2 M€, soit une marge de 13.2% (+140 pb). Notons que ces chiffres intègrent deux effets défavorables : i/ une perte de 7.4 M€ sur les opérations au Mexique (dont le coût devrait tomber à -1/-1.5 M€ en FY 24-25) et ii/ un impact net de l...

Konrad Zomer ... (+2)
  • Konrad Zomer
  • Stephane Beyazian

ODDO : Ericsson abaisse ses prévisions de trafic mondial

>Une révision inédite de 25% - Ericsson a publié hier son rapport annuel « Ericsson Mobility report», une référence de l’industrie pour les prévisions de trafic sur réseau mobile. Les prévisions de trafic sont déterminantes pour les prévisions d’investissements dans les télécoms.La surprise est qu’Ericsson coupe de près de 25% à la baisse ses prévisions de trafic mobile mondial pour 2029 (de 403 ExaBytes/mois à 313 EB/mois, soit de 56 à 42 GB/mois par utilisateur...

 PRESS RELEASE

EQS-News: Nordex Group to restart production in its manufacturing faci...

EQS-News: Nordex SE / Key word(s): Miscellaneous Nordex Group to restart production in its manufacturing facility in Iowa, US 27.06.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement.   Nordex Group to restart production in its manufacturing facility in Iowa, US Hamburg, 27 June 2024. As part of its growth strategy in North America, the Nordex Group is expanding its local production footprint. The company will manufacture nacelles for both the current N163 turbine variant, and a product specifically tailored to the US market, at ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch